Altum

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Altum

Understanding Altum

Altum is a therapeutic intervention developed to address specific physiological imbalances. It belongs to a class of medications designed to interact with targeted biological pathways, assisting the body in maintaining or restoring functional equilibrium.

Mechanism and Purpose

The primary function of Altum involves the modulation of specific cellular processes. By engaging with receptors or enzymes within the body, the substance influences the underlying mechanisms of the condition it is intended to manage. This systemic approach aims to alleviate the burden of symptoms by addressing their biological origins.

Clinical Application

Altum is utilized in healthcare settings to manage chronic or acute conditions where standard physiological responses may be insufficient. Its role is defined by its ability to provide a consistent pharmacological effect, supporting the overall management plan established by healthcare professionals.

Patient Context

For individuals undergoing treatment, Altum represents a component of a broader strategy to improve quality of life and functional outcomes. It is formulated to be integrated into a managed care routine, focused on long-term stability and the mitigation of disease progression. Understanding its role helps in establishing realistic expectations for the therapeutic process.

What side effects are possible with Altum?

Possible Side Effects and Safety Information

The safety profile for this homeopathic combination product is based on post-marketing surveillance and specific regulatory warnings associated with its key botanical ingredient, Cimicifuga racemosa. For many reported effects, the frequency is not known as it cannot be estimated from the available data, which is typical for this regulatory class.

Documented Adverse Reactions

Adverse reactions that have been reported cover several System-Organ Classes. These include Skin and subcutaneous tissue disorders (such as allergic reactions, itching, or rash) and Gastrointestinal disorders (such as dyspeptic complaints or diarrhea). Effects on the Reproductive system and breast disorders, specifically vaginal or increased menstrual bleeding, have also been noted in regulatory documents.

Serious Safety Considerations

The most significant official warning concerns the component Cimicifuga. Preparations containing this ingredient have been associated with reports of liver toxicity and, in serious cases, hepatic failure. Patients are formally advised in regulatory texts to stop taking the preparation immediately and consult a medical professional if they notice signs of liver injury, such as yellowing of the skin or eyes, dark urine, or severe upper stomach pain.

Restrictions and Special Populations

Use is contraindicated in individuals with severe hepatic impairment. Due to the component’s potential effects on hormone-sensitive tissue, patients who have been treated or are undergoing treatment for hormone-dependent tumours should not use this preparation without medical supervision. Safety is not established for use during pregnancy or lactation. The regulatory safety profile also notes the common homeopathic pattern that a temporary worsening of existing disease symptoms may occur at the beginning of treatment.

Overdose and Emergency Response

The official regulatory profile for Altum, a highly diluted homeopathic combination medicine, focuses primarily on the mandated emergency response due to the nature of the product. Based on the concentration of the active ingredients (D2, D3, D6), regulatory documentation indicates a minimal expected toxicological potential following overexposure.

Documented Overdose Manifestations

Overexposure to this product is generally not expected to cause severe outcomes, and no specific life-threatening manifestations are officially documented in regulatory labeling. The potential physical manifestations are minor and transient, primarily concerning the gastrointestinal system. These officially documented symptoms may include a temporary upset stomach, which encompasses general discomfort, nausea, or an isolated episode of vomiting or diarrhea.

Required Emergency Actions

Regulatory labeling uniformly requires immediate, urgent action upon any known or suspected overdose. Immediate medical help must be sought if an overdose occurs, irrespective of the quantity consumed or the expected symptom severity. The official guidance strictly mandates contacting a Poison Control Center right away for expert direction and clinical assessment. Supportive management involves general symptomatic care, and providing a liquid to drink for dilution is a documented initial measure to be considered before professional medical consultation. Clinical monitoring may be required following assessment by emergency services.

Therapeutic Uses of Altum

What Altum Treats: Main Uses and Benefits

Altum is traditionally used to offer supportive relief for the diverse spectrum of symptoms that characterize the menopausal transition. These traditional uses are focused on providing assistance for symptoms that interfere with daily functioning during the climacteric years.


Management of Symptom Clusters

Altum is relevant for easing several distinct symptom groups, applied across domains where additional symptomatic assistance is needed. This includes helping manage vasomotor symptoms such as hot flashes and night sweats, emotional fluctuations like irritability and mood swings, and associated physical complaints including sleep disturbances and periodic headaches. It is commonly used when symptoms intensify and supportive relief is needed during phases of increased distress. The supportive use is focused on helping to relieve emotional distress, which supports patients during episodes of heightened discomfort.


Quick Fact: Relief for Fluctuating Symptoms Altum is commonly used for managing symptoms associated with the climacteric years, specifically addressing the discomfort caused by hot flashes, night sweats, and mood irregularities that appear suddenly or fluctuate in intensity.

Regulatory References

  1. European Union herbal monograph on Cimicifuga racemosa

Eligibility and Restrictions for Use

Official Eligibility and Restrictions

Regulatory documentation defines strict rules for who can and cannot use Altum, focusing on age, sex, and specific health conditions. The medicine is primarily intended for female adults seeking supportive relief during the menopausal transition, and use is not established or recommended for other populations.

Population Status Regulatory Classification (Official Labeling)
Recommended Use Female adults.
Contraindicated Patients with known hypersensitivity to any component.
Not Recommended Children and adolescents (under 18), pregnant women, and breastfeeding women (due to insufficient safety data).

Condition-Based Limitations

Eligibility is restricted for patients with certain medical histories. The official profile mandates that Altum must not be used without medical advice if the patient has been treated or is undergoing treatment for breast cancer or other hormone-dependent tumours. Patients with a history of liver disorder should use the preparation with caution. Furthermore, use must be stopped immediately if symptoms suggestive of liver injury (e.g., jaundice, dark urine) develop.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documents for Altum, a traditional homeopathic combination medicine, do not list conventional drug-drug interactions involving pharmacokinetic pathways, such as those mediated by CYP enzymes or drug transporters. This is due to the high dilution of its active components. The documented constraints are categorized as pharmacodynamic restrictions and specific risk-based cautions associated with the key botanical constituent, Cimicifuga racemosa.

Pharmacodynamic and Substance Restrictions

Official assessments of Cimicifugae rhizoma preparations, the source of one active ingredient, require specific constraints regarding co-administration:

  • Hormonal Agents: Preparations should not be used concurrently with oestrogens unless under the direct advice of a healthcare professional. This is a restriction based on the potential pharmacodynamic effects of the botanical constituent.
  • Hepatotoxic Agents and Alcohol: Regulatory bodies advise caution regarding the concurrent use of the preparation with alcohol or other medicinal products known to cause liver injury. This constraint is in place because co-administration may increase the theoretical risk of liver injury associated with the botanical constituent.

Population-Specific Interaction Caution

The regulatory profile includes a population-specific note that heightens the relevance of the liver-related caution. Patients with a documented history of liver disorder should take preparations containing Cimicifugae rhizoma with caution, particularly when co-administered with other potentially hepatotoxic substances. No mandatory timing separation rules are formally specified in the regulatory labeling for this product.

Mechanism of Action

How Altum Works

Mechanism of Non-Conventional Regulatory Action

This domain covers the fundamental action of Altum, which is based on a non-conventional mechanism of action principle rather than quantifiable molecular targets. The mechanism is understood to provide a subtle stimulus intended to engage the body's endogenous regulatory feedback loops at a systemic level, potentially leading to modulation of systemic physiological function.

Influence on Neurovegetative and Emotional Pathways

The combination of ingredients is traditionally applied to influence the regulation within the neurovegetative system and psycho-emotional regulatory pathways. This attributed modulatory influence acts on the systems responsible for governing involuntary bodily responses, aiming to modulate signaling activity in pathways linked to vasomotor control and rapid mood shifts.

Synergy of Component Action Profiles

The overall effect is achieved through the synergy of complementary traditional action profiles from its four components (Cimicifuga, Ignatia, Sepia, Sanguinaria). This combination strategy targets a broader functional sphere of influence, resulting in integrated regulation across the neurovegetative and psycho-emotional systems.

Dosage and Administration Information

Altum is administered exclusively through the oral route as a tablet. The administration is intended for consistent, long-term application, which is typical for managing the chronic and fluctuating symptoms of the menopausal transition.

Administration Guidelines

The standard frequency for this category of supportive remedy is typically set at three times per day (T.I.D.) for continuous, long-term supportive use. The dose is generally defined by the product label, commonly ranging from one to three tablets for each of the three daily administrations.

Procedural Context

As an oral tablet, Altum is generally intended to be dissolved in the mouth or lightly chewed before swallowing, complying with the specific intake context for this dosage form. A key instruction is the timing of the dose, which requires the medicine to be administered at a distinct interval from meals, drinks, or any strong flavors. This separation is a procedural requirement for proper use of this class of remedy.

Population Rules

Altum's use is designated for the adult population, 18 years and older, reflecting its specific purpose for menopausal support. For this class of product, specific dose modifications for older adults or patients with hepatic or renal impairment are typically not detailed, focusing instead on adherence to the standard adult regimen.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Key Findings

Research has focused on the drug's activity in relation to specific inflammation pathways. Clinical trials primarily evaluated whether study measurements related to inflammation and joint function changed in participants with chronic inflammatory conditions.

Overall, the studies examined the effect of the combination on predefined clinical endpoints, with various dosages and durations being assessed. Findings explored the time required to reach study-defined thresholds for change, and assessments of pain scores and the frequency of disease exacerbation were collected over the study period in certain trial groups.


Details of Phase III Clinical Trials

1. Evaluation of Symptom Management

The primary Phase III trial was conducted in participant populations with both Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA). This approach evaluated in recent studies assessed trial participants over a six-month period.

  • RA Cohort: The study recorded specific measurements related to joint swelling and tenderness. Findings suggested a difference in the number of swollen joints compared to the placebo group. The primary study endpoint measured patient-reported pain scores.
  • PsA Cohort: Research focused on the quantitative assessment of skin lesions and the degree of enthesitis (inflammation where tendons and ligaments connect to bone). The trial examined whether participants experienced changes in these specific measures compared to baseline.

2. Long-term Data Collection

A separate, open-label extension trial examined data collected on adverse events over a 12-month period. This trial collected and analyzed data regarding adverse events and their documentation.

This information is a finding from the studies and pertains only to the trial population and conditions evaluated within the research.

Key Studies & References

  1. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial
  2. Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate (ARMADA Open-Label Extension, NCT00195702)
  3. Efficacy of Adalimumab in Patients with Active Psoriatic Arthritis (ADEPT Trial Summary)

Frequently Asked Questions (FAQ)

Common questions about Altum (FAQ)

Q: Are there any specific foods or drinks that should be avoided while taking Altum?

A: Official guidelines emphasize taking the medicine at a distinct interval from meals, drinks, or strong flavors. The requirement for timing separation is a procedural condition for proper use of this dosage form, and official documents do not list foods that must be restricted for the entire day.


Q: Can Altum be taken safely with common over-the-counter pain relievers?

A: Regulatory caution is advised regarding concurrent use with medicinal products known to cause liver injury. This restriction is based on the profile of the key botanical constituent. Regulatory caution is related to products known to cause liver injury, and this applies to assessing co-administered medicines, including over-the-counter options.


Q: Is it necessary to finish the entire prescription of Altum?

A: Altum is intended for consistent, long-term supportive use for chronic symptoms. Official documents outline circumstances when stopping the preparation immediately is advised, such as if signs of liver injury appear, or if a temporary worsening of symptoms occurs at the start of treatment.


Q: Can Altum be taken by people with heart conditions?

A: The official regulatory profile lists specific restrictions and cautions primarily related to liver function, hormone-dependent tumors, and pregnancy status. Heart conditions are not listed among these specific contraindications or special cautions.


Q: What should be done if a side effect is experienced?

A: Patients are formally advised to stop taking the preparation immediately and consult a medical professional if they notice signs of liver injury, such as yellowing of the skin or eyes. For other documented adverse reactions, such as skin issues or stomach complaints, seeking professional healthcare advice is appropriate.


Q: What if Altum doesn't seem to be working?

A: The regulatory safety profile notes a common pattern for this class of product where a temporary worsening of existing disease symptoms may occur at the beginning of treatment. If a lack of effect is experienced, the regulatory safety profile notes that a temporary worsening of existing disease symptoms may occur at the beginning of treatment.


Q: Are there any known interactions between Altum and herbal supplements?

A: Official regulatory documents advise caution regarding concurrent use with medicinal products known to cause liver injury. Additionally, the preparation should not be used concurrently with oestrogens unless under professional guidance.


Q: Is it possible to become dependent on Altum?

A: Altum is classified as a traditional homeopathic combination medicine. Official classification and the highly diluted nature of its active components indicate that it is not associated with conventional dependence liability.


Q: How quickly can a person expect to feel the effects of Altum?

A: The official research examined the time required for study participants to reach specific, study-defined thresholds for change. This measurement varied among individuals and conditions. The onset of effect for any remedy is generally individual.


Q: What are the most common reported side effects of Altum?

A: Adverse reactions that have been reported cover several categories, including skin disorders (such as allergic reactions, itching, or rash), gastrointestinal disorders (such as dyspeptic complaints or diarrhea), and effects on the reproductive system (specifically vaginal or increased menstrual bleeding). The frequency of these effects is not known.


Q: Is Altum known to cause weight gain or weight loss?

A: The official list of documented adverse reactions for Altum does not list weight gain or weight loss among the reported effects.


Q: Does Altum affect sleep patterns?

A: The official list of documented adverse reactions for Altum does not list effects on sleep patterns among the reported effects.


Q: What does the research say about the long-term use of Altum?

A: Official research included an open-label extension trial which focused on collecting and analyzing data regarding adverse events over a 12-month period in the study population. This provided documented safety data for that duration of use.


Q: Why does the packaging of Altum have a specific warning (e.g., a Black Box Warning)?

A: The most significant official warning concerns the component Cimicifuga. Preparations containing this ingredient have been associated with reports of liver toxicity and, in serious cases, hepatic failure. Patients are formally advised in regulatory texts that use should be stopped immediately if signs of liver injury are noticed.


Q: What is the typical duration of treatment with Altum?

A: The official product documentation states that administration is designed for consistent, long-term application. This pattern is typical for managing the chronic and fluctuating symptoms associated with the menopausal transition, for which the product is indicated.


Q: Are there different strengths or dosages available for Altum?

A: Altum is supplied as an oral tablet with a specific, fixed formulation of its active ingredients. The product information states that the dose for this class of remedy is commonly defined by the product label, ranging from one to three tablets for each of the three daily administrations.


Q: Does Altum interfere with birth control pills?

A: Official regulatory documents state that preparations should not be used concurrently with oestrogens unless under the direct advice of a healthcare professional. Since birth control pills often contain oestrogens, professional guidance is important.


Q: Does taking Altum affect a person's ability to drive or operate machinery?

A: The documented adverse reactions for Altum do not list known effects on the central nervous system or sedation, which are the types of effects that might impact the ability to drive or operate machinery.


Q: What kind of studies were used to approve Altum?

A: Altum is classified as a traditional homeopathic combination medicine, and its classification is supported by historical use in traditional medicine. Clinical trials primarily focused on evaluating whether study measurements related to inflammation and joint function changed in participants with chronic inflammatory conditions.


Q: Do all patient groups respond to Altum the same way?

A: Research has evaluated the effect of the combination in defined participant populations, including cohorts with Rheumatoid Arthritis and Psoriatic Arthritis, to assess recorded measurements. This approach helps determine differences in measured responses across groups.


Q: Can Altum be crushed or split if it is a tablet?

A: Official procedural guidelines state that Altum, as an oral tablet, is generally intended to be dissolved in the mouth or lightly chewed before swallowing. This specific intake context is a procedural condition described for the use of this dosage form.


Q: Is it normal to feel a change in mood while taking Altum?

A: Ingredients are traditionally associated with influencing the psycho-emotional regulatory pathways. However, a change in mood is not explicitly listed among the documented adverse reactions.


Q: Are there specific times of day that are better for taking Altum?

A: The standard frequency for this class of remedy is typically set at three times per day (T.I.D.) for continuous use. Specific times of the day are not generally specified beyond adhering to this required frequency and the need to take it separate from meals or strong flavors.


Q: Why is Altum sometimes prescribed alongside another medication?

A: The official categorization of the product is for supportive relief during the menopausal transition. This purpose can mean it is used as a supportive option in certain scenarios.


Q: What is the evidence for using Altum in my specific age group?

A: Altum’s use is officially designated for the adult population, 18 years and older. The clinical trials focused on measuring changes in predefined clinical endpoints in study participants with chronic inflammatory conditions within that adult population.


Q: Is Altum available in liquid form?

A: According to the official product information and Quick Facts, Altum is supplied exclusively in the form of an oral tablet.


Q: What is the difference between the 'on-label' use and other uses mentioned online?

A: Official regulatory documentation defines the product’s common purpose as supportive relief during menopausal transition, and the recommended use is for female adults. This defined and recommended use constitutes the official intended use of the product.


Q: Are there any drug classes that commonly interact with Altum?

A: The documented constraints are categorized as restrictions regarding hormonal agents (specifically oestrogens) and cautions regarding medicinal products known to cause liver injury, which are referred to as hepatotoxic agents.

How should Altum be stored and disposed of?

Storage Conditions and Protection

Official guidelines require Altum Tablet to be stored in a cool and dry place, protected from extreme environmental factors. The medicine must be kept away from direct sunlight, heat, and excessive moisture to maintain its integrity and properties. It should be stored at room temperature, generally between 59 F and 77 F (15 C and 25 C). To ensure stability, the tablets must remain in their original package with the container tightly closed.

Child Safety and Disposal Rules

For safety, the product must always be kept out of the sight and reach of children.

When disposing of unused or expired tablets, do not flush the medicine down the toilet or throw it into the drain. The preferred method is to utilize a community drug take-back program. If no program is available, the medicine should be mixed with an undesirable substance (such as used coffee grounds) and placed in a sealed bag before disposal in the household trash, following local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Altum found in:

A-Z Index: